Total Payments
$1,403
2024 Payments
$334.87
Companies
12
Transactions
94
Medicare Patients
1,692
Medicare Billing
$167,309
Payment Breakdown by Category
Food & Beverage$1,403 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,403 | 94 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $820.75 | 61 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $223.02 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $78.81 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $47.06 | 2 | $0 (2024) |
| Lilly USA, LLC | $37.39 | 2 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $36.59 | 2 | $0 (2024) |
| QOL Medical, LLC | $35.37 | 3 | $0 (2021) |
| Ardelyx, Inc. | $35.19 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $31.70 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $24.04 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $334.87 | 23 | ABBVIE INC. ($132.64) |
| 2023 | $426.96 | 28 | ABBVIE INC. ($213.37) |
| 2022 | $562.19 | 37 | ABBVIE INC. ($461.18) |
| 2021 | $78.99 | 6 | QOL Medical, LLC ($35.37) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: CRITICAL CARE | ||||||
| 06/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Gastroenterology | ||||||
| 02/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Immunology | ||||||
| 01/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Gastroenterology | ||||||
| 12/14/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: CRITICAL CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 298 | 298 | $190,344 | $28,835 |
| 2022 | 4 | 410 | 412 | $264,594 | $39,305 |
| 2021 | 4 | 513 | 515 | $335,264 | $50,542 |
| 2020 | 4 | 471 | 475 | $313,148 | $48,626 |
Total Patients
1,692
Total Services
1,700
Medicare Billing
$167,309
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 134 | 134 | $84,040 | $12,440 | 14.8% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 53 | 53 | $41,888 | $5,996 | 14.3% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 58 | 58 | $38,390 | $5,582 | 14.5% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 53 | 53 | $26,026 | $4,817 | 18.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 190 | 191 | $117,810 | $17,168 | 14.6% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 97 | 98 | $66,374 | $9,614 | 14.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 62 | 62 | $50,138 | $6,935 | 13.8% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 61 | 61 | $30,272 | $5,587 | 18.5% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 224 | 224 | $139,794 | $20,909 | 15.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 127 | 129 | $86,590 | $12,554 | 14.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 92 | 92 | $74,780 | $10,521 | 14.1% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 70 | 70 | $34,100 | $6,559 | 19.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 194 | 194 | $123,574 | $18,671 | 15.1% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 112 | 114 | $79,354 | $11,955 | 15.1% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 98 | 98 | $76,824 | $11,385 | 14.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 67 | 69 | $33,396 | $6,615 | 19.8% |
About Tiffany Ray, CRNA
Tiffany Ray, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Horn Lake, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114097615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tiffany Ray, CRNA has received a total of $1,403 in payments from pharmaceutical and medical device companies, with $334.87 received in 2024. These payments were reported across 94 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,403).
As a Medicare-enrolled provider, Ray has provided services to 1,692 Medicare beneficiaries, totaling 1,700 services with total Medicare billing of $167,309. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered|Nurse Anesthetist, Certified Registered
- Location Horn Lake, MS
- Active Since 11/09/2006
- Last Updated 03/04/2025
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1114097615
Products in Payments
- RINVOQ (Biological) $301.56
- XIFAXAN (Drug) $223.02
- HUMIRA (Biological) $152.02
- SKYRIZI (Biological) $118.60
- MAVYRET (Drug) $104.60
- ENTYVIO (Biological) $78.81
- LINZESS (Drug) $76.43
- CREON (Drug) $55.06
- TERLIVAZ (Drug) $47.06
- OMVOH (Drug) $37.39
- OCALIVA (Drug) $36.59
- SUCRAID (Drug) $35.37
- IBSRELA (Drug) $35.19
- DUPIXENT (Biological) $31.70
- INJECTAFER (Drug) $24.04
- TREMFYA (Drug) $18.60
- DIFICID (Drug) $14.49
- VIBERZI (Drug) $12.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.